NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Geneseeq

Geneseeq

Private
TorontoHealthcare & Life Scienceshttps://zh.geneseeq.com/

Last Round

Growth Equity

Oct 19, 2020

Est. Valuation

$902.2M

Total Funding Raised

$531.71M

Company Overview

Geneseeq is a precision oncology company that provides genomic profiling technology to accelerate precision cancer care.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

precision medicinecomprehensive genomic profilingCGPnext-generation sequencingNGSmolecular diagnosticscancer genomicsliquid biopsybioinformaticstargeted therapyin vitro diagnosticsIVDclinical oncologycfDNA testingcompanion diagnosticsgenomic data analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geneseeq Comparables

Compare Geneseeq with similar companies based on industry and business-model similarity.

Geneseeq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HaploX
87%
Beijing Geneplus Technology
87%
求臻医学
87%

Geneseeq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 19, 2020
Growth EquityJan 5, 2020
Series DDec 26, 2019
Series CNov 23, 2017
Series CJul 20, 2017
Series B Extension
Feb 1, 2017

Geneseeq Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 10, 2025

    PanTRKare gene fusion kit approved by China's NMPA.

  • May 21, 2025

    Showcasing liquid biopsy research at ASCO 2025.

Geneseeq Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Geneseeq Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Geneseeq's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range35
Year Founded2012
Last FundingOct 19, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.